Neurocrine Biosciences | Aktuelle Verpflichtungen



Current Liabilities Veränderung Datum
AbbVie USD 36.4B 2.35B 2025-03
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 70.41M 18.04M 2025-06
ALKERMES USD 505.96M 62.23M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 23.01B 91M 2025-03
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Cytokinetics USD 159.73M 19.95M 2025-03
Dynavax Technologies USD 68.38M 10.26M 2025-03
Exelixis USD 336.11M 62.99M 2025-07
Gilead Sciences USD 12B 279M 2024-12
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Incyte USD 1.28B 608.18M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Prothena USD 48.5M 2.08M 2024-12
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Repligen USD 152M 25.21M 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06
Ultragenyx Pharmaceutical USD 291.67M 52.48M 2025-03
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Neurocrine Biosciences Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.